Kevin T. Conroy - Dec 31, 2019 Form 5/A - Amendment Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Dec 31, 2019
Transactions value $
$0
Form type
5/A - Amendment
Date filed
4/29/2025, 04:08 PM
Date Of Original Report
Feb 14, 2020
Next filing
Apr 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Gift $0 -28.7K -3.26% $0.00 851K May 6, 2019 Direct
transaction EXAS Common Stock Gift $0 +43.1K +5.07% $0.00 894K Nov 27, 2019 Direct F1, F3
transaction EXAS Common Stock Gift $0 -43.1K -66.16% $0.00 22.1K Nov 27, 2019 Held in Grantor Retained Annuity Trust F1
transaction EXAS Common Stock Gift $0 -22.1K -100% $0.00 0 Nov 27, 2019 Held in Grantor Retained Annuity Trust F2
holding EXAS Common Stock 25.9K Dec 31, 2019 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held in Kevin T. Conroy 2014 Grantor Retained Annuity Trust transferred to the reporting person.
F2 Represents shares held in Kevin T. Conroy 2014 Grantor Retained Annuity Trust transferred to grantor retained annuity trusts for the benefit of the reporting person's daughters.
F3 In addition to the shares of Common Stock reported on this Form 5, which total 919,731 shares, Mr. Conroy also held, in the aggregate, an additional 1,138,101 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.